The people doing the work.

Edward Francis is a life sciences executive and entrepreneur with more than 20 years of experience spanning molecular biology research, business development, and executive leadership. He has helped bring more than 50 natural health products and technologies to global markets and played a leading role in growing Prince Edward Island's bioscience cluster from $100 million to $650 million in annual revenue, including securing $50 million in government funding for a flagship life sciences infrastructure initiative.

Edward holds an M.Sc. in Molecular Biology and a B.Sc. from the University of Prince Edward Island, certifications in Project Management Professional (PMP), Good x Practice (GxP), and MIT Venture Mentorship, and currently holds board and mentorship positions with Health Emergency Readiness Consortium of Canada, Lab2Market, Creative Destruction Lab, Propel ICT and the Emergence BioScience Accelerator.

Dr. Hunter Land brings more than 20 years of R&D expertise across 25 therapeutic indications. He was GW Pharma's first full-time U.S. R&D employee, where he contributed to the development of Epidiolex and Sativex and co-authored treatment protocols for refractory epilepsy, multiple sclerosis, and pain.

Dr. Land has presented at more than 50 scientific conferences, is a named inventor on nine patent applications, has authored over 20 publications, and serves as a guest lecturer at the University of Wisconsin and the University of Colorado Skaggs School of Pharmacy.

Dr. Mark Lindsay is one of the most sought-after chiropractors and soft tissue specialists among professional, world, and Olympic athletes, and by organizations including the NHL, NFL, NBA, and MLB. He is a graduate of Palmer Chiropractic College and the University of Guelph, where he earned a Bachelor of Science in Kinesiology. In 1996, Dr. Lindsay was named Outstanding Field Doctor by the Canadian Chiropractic Sports Fellowship for his intensive work with Olympic champion Donovan Bailey.

His career includes 35 years supporting elite athletes and teams. He co-founded Carnyx Therapeutics, Kelvin Therapeutics and Entourage Diagnostics, and is a Research Fellow at the Steadman Philippon Research Institute.

His background includes more than 2,500 hours of postgraduate coursework at the Carrick Institute and extensive fascia training with Dr. Guy Voyer. He authored Fascia: Clinical Applications for Health and Human Performance.

Sources: Carnyx biography

Christopher Cherry is a chartered professional accountant with more than 20 years of accounting and audit experience. He has held Chief Financial Officer and Corporate Secretary roles at publicly traded companies.

Dr. Trina Hazzah earned her Doctor of Veterinary Medicine from Tuskegee University in 2006 and completed a three-year residency in medical oncology. She is a board-certified veterinary oncology specialist and the founder of Green Nile. Over the past several years she has treated hundreds of veterinary cancer patients using integrative approaches, published peer-reviewed research and co-authored textbooks on the subject.